Dyadic International Inc (DYAI)
1.480
+0.01
(+0.69%)
USD |
NASDAQ |
May 02, 16:00
Dyadic International Cash from Investing (Quarterly): 0.0342M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.0342M |
September 30, 2023 | 3.527M |
June 30, 2023 | 1.121M |
March 31, 2023 | 2.767M |
December 31, 2022 | 0.6179M |
September 30, 2022 | -1.310M |
June 30, 2022 | -1.156M |
March 31, 2022 | -0.5209M |
December 31, 2021 | 4.50M |
September 30, 2021 | 4.006M |
June 30, 2021 | 2.50M |
March 31, 2021 | -5.784M |
December 31, 2020 | 0.0382M |
September 30, 2020 | 11.46M |
June 30, 2020 | 8.930M |
March 31, 2020 | 1.698M |
December 31, 2019 | 1.34M |
September 30, 2019 | 1.263M |
June 30, 2019 | 2.099M |
March 31, 2019 | 3.006M |
December 31, 2018 | 1.910M |
September 30, 2018 | 1.233M |
June 30, 2018 | 0.3093M |
March 31, 2018 | -0.123M |
December 31, 2017 | 1.879M |
Date | Value |
---|---|
September 30, 2017 | -4.738M |
June 30, 2017 | -5.480M |
March 31, 2017 | 7.527M |
December 31, 2016 | 6.146M |
September 30, 2016 | -1.120M |
June 30, 2016 | -47.58M |
March 31, 2016 | -0.0048M |
December 31, 2015 | 66.98M |
September 30, 2015 | -0.0563M |
June 30, 2015 | -0.1294M |
March 31, 2015 | 0.0436M |
March 31, 2014 | -0.0646M |
December 31, 2013 | -0.1936M |
September 30, 2013 | -0.0885M |
June 30, 2013 | -0.0415M |
March 31, 2013 | -0.0904M |
September 30, 2012 | -0.0296M |
June 30, 2012 | -0.0084M |
March 31, 2012 | -0.0309M |
December 31, 2006 | -0.056M |
September 30, 2006 | -0.0579M |
June 30, 2006 | -0.4565M |
March 31, 2006 | -0.2892M |
December 31, 2005 | -0.0917M |
September 30, 2005 | -0.1537M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.784M
Minimum
Mar 2021
11.46M
Maximum
Sep 2020
1.954M
Average
1.34M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
AIM ImmunoTech Inc | -0.214M |
Perspective Therapeutics Inc | -0.089M |
Protalix BioTherapeutics Inc | -0.342M |
Electromed Inc | -0.087M |
Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.9234M |
Free Cash Flow | -6.727M |
Free Cash Flow Per Share (Quarterly) | -0.032 |
Free Cash Flow to Equity (Quarterly) | -0.9234M |
Free Cash Flow Yield | -15.78% |